Jim Watson

Opinion author

Jim Watson is a vice president at Project Farma and has more than 25 years of experience in the pharmaceutical industry. He has worked for small and established pharmaceutical and biotech organizations launching early phase manufacturing strategy, conceptual design, user requirement specifications, verification, validation, facility turnover and facility operations.

Biopharma collage of scientist, deals, and pills

Opinion

When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?

Here’s how to assess whether to develop a new therapy by building a proprietary platform, acquiring another company or asset or partnering with an established entity.

April 24, 2024

6 min read

Anshul Mangal